Rune E. Kuhre

GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines.

Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.

Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine.

Stability of glucagon-like peptide 1 and glucagon in human plasma.

Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors.

The regulation of function, growth and survival of GLP-1-producing L-cells.

The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.

Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes.

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma.

The biology of glucagon and the consequences of hyperglucagonemia.

Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes.

Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite.

Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion.

Why is it so difficult to measure glucagon-like peptide-1 in a mouse?

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.

On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat.

Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.

Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice.

Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients.